Skip to search formSkip to main contentSkip to account menu

OKY 046

Known as: OKY-046 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Background: Because thromboxane A2 is implicated in the pathophysiology of acute lung injury, the aim of this study was to… 
1990
1990
To examine the effects of endogenous thromboxane A2 on the development of diabetic nephropathy, we administered OKY-046, an… 
1989
1989
The effects of OKY-046, a selective thromboxane A2 (TXA2) synthetase inhibitor, and ONO-3708, a novel TXA2 receptor antagonist… 
Highly Cited
1986
Highly Cited
1986
The effect of a selective thromboxane synthetase inhibitor, OKY-046, and a selective 5-lipoxygenase inhibitor, AA-861, on… 
1985
1985
We tested the effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in…